WHETHER POLICE CAN REGISTER FIR IN DRUG MATTERS – A POINT OF LAW
It is seen that in many cases the police has registered FIR in drug cases and to make it more perfect and to ensure that it should not fail prima…
OPEN VIOLATION OF DPCO, 2013 BY M/S SANOFI INDIA LTD, M/S ZYDUS CADILA HEALTHCARE LTD, DR. REDDYS LAB. & STANCARE (RANBAXY LABORATORIES LTD.)- LAXITY CONTINUES IN NPPA
After introduction of DPCO 2013, the position is becoming murkier and it is now clear that the breeding corruption in NPPA is the sole reason why big companies are not…
CONSTRAINTS ON THE PROMOTION OF ADVERTISEMENTS RELATED TO THE DRUGS
Q: We are engaged in manufacturing and trading of various drugs under the valid license. Kindly advise us, with the help of relevant provisions of “Drugs and Magic Remedies (Objectionable…
ACCOUNTABILITY OF RETAILER/CHEMIST IN THE MATTER OF SALES OF SUBSTANDARD DRUGS
Q: One of my friends runs a retail/chemist shop for selling the drugs/medicines under the valid drug license. Months back, the samples were collected by the Drug Inspector from his…
INTOLLERANCE IN PHARMA INDUSTRY
New Delhi: The Indian pharmaceutical industry is one of the most attractive investment destinations in the world. With ever increasing returns, lowering risks and anticipated multifold growth, investors are more…
CAN A TRADER/WHOLESALER BE HELD LIABLE FOR SUBSTANDARD DRUG?
Q: We are involved in wholesaling the drugs under the conditions of an appropriate license. A drug sample was collected by area Drug Inspector from our premises during the inspection.…
NATIONAL PHARMACEUTICAL PRICING में लूट
National Pharmaceutical Pricing Authority , Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals and the Great Indian Courts part of Great Ramon Circus each ignoring its duty right up to…
GLIPTIN FAMILY LAUNCHED BY MANKIND
NEW DELHI: Mankind Pharma has launched an anti-diabetic product ‘Dynaglipt’ targeting the middle class and rural diabetic patients. The company has launched an affordable anti-diabetic product for the diabetic patients…
EASE OF DOING NEW DRUG APPROVAL BY CDSCO
New Delhi: Narendra Modi, PM of India had given directive to all ministries just after joining the post to follow “ease of business” means fast clearance from government offices. PM…
PHASE IV CLINICAL TRIAL IS HARD NUT TO CRACK FOR INDUSTRY
New Delhi: In the month of July, Joint DCGI has issued letter to most of the FDC applicant (FDC already approved by state licensing authority) to submit protocol for Phase…
